Francisco Rodriguez-Covarrubias, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (General Urology)
    Ineligible company:
    GSK
    Date added:
    Date updated:
    07/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    07/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Asofarma Oncologia
    Date added:
    Date updated:
    07/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    07/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    07/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    MSD; Ferring
    Date added:
    Date updated:
    07/13/2024
Return to Curso en vivo de avances globales en cáncer de próstata: mejores prácticas en terapia hormonal (2022) - Espanol